Treatment of Juvenile Recurrent Parotitis: the Yield of Minimally Invasive Intervention
JRP
1 other identifier
interventional
30
1 country
1
Brief Summary
Juvenile recurrent parotitis (JRP) is an inflammatory disease characterized by recurrent painful swelling of the Parotid gland in the pediatric age. A watchful waiting treatment strategy was acceptable for most children; however, recent studies claimed that a sialoendoscopic intervention may stop the recurrent flare-ups. The Objective of our study: To determine the effectiveness of sialoendoscopy vs. conservative therapy ('watch and wait') alone for Juvenile Recurrent Parotitis Research Endpoints: The study's endpoints will evaluate frequency and severity of flare-ups before and after treatment and Quality of Life parameters as evaluated according to life-quality questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2019
CompletedFirst Posted
Study publicly available on registry
August 30, 2019
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedAugust 30, 2019
August 1, 2019
3 years
August 29, 2019
August 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Frequency of flare-ups
3 years
Quality of Life (QoL ) Questionnaire
3 years
Study Arms (2)
Watchfull waiting
NO INTERVENTIONInterventional
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- age 3-18 y/o at least 2 documented incidents in at least 12 months period
You may not qualify if:
- previous parotis interventions e.g. sialography/sialendoscopy/parotidectomy parotitis due to any other known cause (e.g. bacterial infection, autoimmune disease etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Otolaryngology, Carmel Medical Center
Haifa, 34362, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2019
First Posted
August 30, 2019
Study Start
January 1, 2020
Primary Completion
January 1, 2023
Study Completion
January 1, 2023
Last Updated
August 30, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share